Resources

Letter to government to support Covid-19 vaccines pool

May 2020

Letter signed by Global Justice Now, Just Treatment, Oxfam, STOPAIDS and Nurses United to call on the government to support a global plan for affordable and accessible Covid-19 vaccines around the world. 

Resource thumbail

A Covid-19 vaccine should be affordable for all

March 2020

As coronavirus rips through the world, the race is on to find a vaccine for Covid-19. There are already reports of promising candidates as well the start of human trials. And this progress is largely thanks to public investment in biomedical research and development (R&D). But there is a real danger that, without effective safeguards, big pharmaceutical firms could profiteer from price gouging which would prevent widespread access to coronavirus treatments and threaten the world’s ability to stop the spread of this pandemic.

Resource thumbail

Pharma Trade Secrets: The truth about a trade deal with Trump

November 2019

The prices that our NHS will pay as a result of a US trade deal is under threat. Our chronically underfunded NHS is already struggling to afford spiraling medicine prices. Pharmaceutical companies are charging such high prices that the NHS is increasingly having to reject or ration new, effective medicines because they are unaffordable. And yet, the US pharmaceutical industry is lobbying hard to ensure a US-UK trade deal strengthens the rules that keep prices high as well as to attack the regulations that control prices.

Resource thumbail

Alternatives to the current pharmaceutical system: Activist pack to lobby your MP

December 2018

This briefing is for Global Justice Now local groups and activists to help you to lobby your MP on alternatives to the current corporate-dominated pharmaceutical system.

Resource thumbail

Taking public control of medicines

November 2018

The pharmaceutical industry makes billions in profits from charging high prices for medicines. Meanwhile, people suffer and die from treatable conditions because they can’t afford extortionate prices. This is a system driven by corporate profit that leaves vital medicines out of reach for millions of people – in the UK and around the world. It’s a system that is economically and socially unsustainable and needs urgent reform.

Resource thumbail

The people’s prescription: Re-imagining health innovation to deliver public value

October 2018

Driven by profit rather than public health, the pharmaceutical sector is incentivised to set high prices and deliver short-term returns to shareholders, rather than focus on riskier, longer-term research which leads to critically needed therapeutic advances. The high prices of medicines are causing severe patient access problems worldwide, with damaging consequences for human health and wellbeing. These are symptoms of an innovation model that is broken. This report maps the fault lines of this system and sets out principles for a new one.

Pharma - NHS birthday A5 leaflet

May 2018

As the NHS turns 70, it is locked in a crisis of underfunding. The reasons are many, from government funding cuts to the massive debts racked up as a result of Private Finance Initiatives. But one factor that gets less notice is the rip-off prices the pharmaceutical industry charges for a huge range of drugs.

Resource thumbail

Pharmaceutical campaign: activist lobby guide

March 2018

This briefing provides the key talking points that you can use in a meeting with your MP about our campaign for affordable medicines. The briefing is intended to help you lobby:

- An MP who has not taken action on this campaign

- An MP who has taken action on this campaign or

-An MP that is a member of the business, health or public accounts committees

Please use the lobbying advice that is most relevant to your MP.

Resource thumbail

Pills and profit: MP briefing

February 2018

This briefing for MPs and parliamentarians documents examples of where publicly funded research and development has led to drugs that the public have found difficult to access. It calls for conditions to be attached to public research to ensure drugs are affordable for all patients. 

A guide to university campaigning for affordable medicine

February 2018

Sick of Corporate Greed: The fight for affordable medicine on your campus is an action guide to help university students campaign and affect change.

Sick of corporate greed leaflet

November 2017

Pharmaceuticals campaign leaflet

Imagine if the NHS couldn’t afford to save your life

November 2017

All over the world, drug companies are charging extortionate prices for medicine, preventing people accessing treatment.
It’s time to put people before profit in the global drug industry.

Resource thumbail

Pills and Profits: How drug companies make a killing out of public research

October 2017

UK taxpayers and patients worldwide are being denied the medicines they need, despite the public sector playing a pivotal role in the discovery of new medicines. The UK government is the second largest funder country, after the US, for research and development (R&D) in diseases that predominantly affect poor countries. Across all areas of health R&D, the UK government spent £2.3 billion on health R&D in 2015 alone.